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Development of the cartilaginous capsule of the inner ear is dependent on interactions between otic epithelium and its
surrounding periotic mesenchyme. During these tissue interactions, factors endogenous to the otic epithelium influence the
differentiation of the underlying periotic mesenchyme to form a chondrified otic capsule. We report the localization of Sonic
hedgehog (Shh) protein and expression of the Shh gene in the tissues of the developing mouse inner ear. We demonstrate in
cultures of periotic mesenchyme that Shh alone cannot initiate otic capsule chondrogenesis. However, when Shh is added
to cultured periotic mesenchyme either in combination with otic epithelium or otic epithelial-derived fibroblast growth
factor (FGF2), a significant enhancement of chondrogenesis occurs. Addition of Shh antisense oligonucleotide (AS) to
cultured periotic mesenchyme with added otic epithelium decreases levels of endogenous Shh and suppresses the
chondrogenic response of the mesenchyme cells, while supplementation of Shh AS-treated cultures with Shh rescues
cultures from chondrogenic inhibition. We demonstrate that inactivation of Shh by targeted mutation produces anomalies
in the developing inner ear and its surrounding capsule. Our results support a role for Shh as a regulator of otic capsule
formation and inner ear development during mammalian embryogenesis. © 2002 Elsevier Science (USA)
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Reciprocal inductive interactions between otic epithe-
lium and its surrounding periotic mesenchyme are essential
to the morphogenesis and cytodifferentiation of the mam-
malian inner ear. During formation of the cartilaginous otic
capsule, condensations of mesenchyme appear in the peri-
otic region in response to induction by the otic epithelium.
These regions of condensed mesenchyme synthesize a type
II collagen-rich extracellular matrix and form a fully chon-
drified otic capsule that serves as the template for the
subsequent formation of the endochondral bony labyrinth
(Noden and Van De Water, 1986). Condensation formation
and type II collagen accumulation also occur during capsule
1 To whom correspondence should be addressed. Fax: (718) 430-
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240chondrogenesis in vitro (Frenz and Van De Water, 1991;
Frenz et al., 1992, 1994).
At early stages of development (embryonic age 9.5–10.5
days), the epithelium of the otocyst is required to initiate
chondrogenesis in cultured periotic mesenchyme (Frenz
and Van De Water, 1991). Correspondingly, factors that are
endogenous to the epithelium of the otocyst have a signifi-
cant influence on capsule chondrogenesis. Signaling by
fibroblast growth factors (e.g., FGF2), which are present in
the otic epithelium at embryonic age 10.5 (E10.5) days, is
sufficient for initiation of periotic mesenchyme chondro-
genesis (Frenz et al., 1994; Frenz and Liu, 1998), while
signaling by transforming growth factor-beta1 (TGF1) and
related bone morphogenetic protein (BMP2) act to modulate
this process (Frenz et al., 1992, 1996a). TGF1 and BMP2 are
localized to sites of active epithelial–mesenchymal interac-
tions in the developing mouse inner ear (Frenz et al., 1992,
1996a). Furthermore, TGF1 can act synergistically with
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FGF2 to potentiate its inductive effects on capsule chon-
drogenesis, thereby eliciting a full chondrogenic response
(Frenz et al., 1994).
Sonic hedgehog (Shh) encodes a secreted protein that acts
as an inductive signal during development (Roberts et al.,
1995). This protein undergoes autoproteolysis to generate
two peptides (Lee et al., 1994; Bumcrot et al., 1995; Porter et
al., 1995): a 19-kDa amino peptide containing the signaling
activity of Shh and a 25-kDa carboxyl peptide containing
the autoprocessing activity of Shh (Marti et al., 1995;
Roelink et al., 1995). Shh that is expressed in the developing
notochord induces floor plate formation within the adjacent
neural tube (Echelard et al., 1993; Fan et al., 1995; Roelink
et al., 1995). In the developing limb, Shh signals the
anteroposterior patterning mediated by the zone of polariz-
ing activity (Riddle et al., 1993), while during somite
formation, Shh controls determination of sclerotome and
myotome lineages (Lassar and Munsterberg, 1996). Further-
more, targeted disruption of the Shh gene, resulting in
deletion of the core of the amino-terminal domain struc-
ture, demonstrates the critical role that Shh signaling plays
in patterning of the developing brain, spinal cord, axial
skeleton, and limbs (Chiang et al., 1996).
Expression of Shh in epithelial cells prior to the conden-
sation of underlying mesenchyme during tooth, hair,
feather, whisker, and lung development (Nohno et al., 1995;
Bitgood and McMahon, 1995; Iseki et al., 1996) suggests the
involvement of Shh in the epithelial–mesenchymal inter-
actions that govern organ development. We have investi-
gated the role of Shh in the epithelial–mesenchymal inter-
actions that guide the differentiation and development of
the capsule of the mouse inner ear. We demonstrate the
distribution pattern of Shh protein and expression of the
Shh gene in otic epithelium and periotic mesenchyme and
have tested the effects of the 19-kDa Shh peptide on
chondrogenesis in cultured periotic mesenchyme. We dem-
onstrate the consequences of loss of Shh function on otic
capsule chondrogenesis by testing the effects of antisense
oligonucleotide (AS) complementary to a region of the
murine Shh gene, and the ability of excess Shh peptide to
rescue chondrogenesis in Shh AS-treated cultures. In a
complementary in vivo study, we have evaluated the mor-
phology of the inner ear and its capsule in mice with a
targeted mutation of the Shh gene. Our results provide
evidence of the necessity for Shh in otic capsule formation
and inner ear morphogenesis in situ.
MATERIALS AND METHODS
High-density culture. Periotic mesenchyme or periotic mesen-
chyme with added otic epithelium (periotic mesenchyme  otic
epithelium) was isolated from CBA/C57 BL6 (NCI) mouse embryos
of E10.5 days or E14 days and cultured at high density, as described
(Frenz and Van De Water, 1991). Periotic mesenchyme was disso-
ciated then resuspended in Ham’s F-12 culture medium supple-
mented with 10% fetal bovine serum (FBS) at a density of 2.5 107
cells/ml. Ten-microliter droplets of cell suspension were plated in
the centers of wells of a four-well tissue culture plate (Nunc). After
a 1-h incubation at 37°C, cultures were maintained for 48 h in 1 ml
of medium containing or not containing one or more of the
following growth factors: 19 kDa Shh amino-terminal peptide (1,
10, or 100 ng/ml; a gift of Dr. A. McMahon); TGF1 (1 or 10 ng/ml;
R&D Systems); FGF2 (1 ng/ml; R&D Systems); or BMP2 (1 or 10
ng/ml; Genetics Institute). Following exchange of the initial ml of
culture medium, subsequent changes occurred every 48 h. Cultures
were maintained for 7 days. In cultures of periotic mesenchyme 
otic epithelium, equivalent amounts of otic epithelium per culture
were mixed into the cell suspension prior to cell seeding (Frenz and
Van De Water, 1991). In some mesenchyme  epithelium cultures,
oligonucleotides (60 g/ml; described below) were added in the
medium 1 h after cell seeding, and maintained for 7 days with daily
medium exchanges. Rescue cultures were treated with Shh anti-
sense oligonucleotide (30 or 60 g/ml) on days 1–4, then treated
with Shh peptide (75 ng/ml) on days 2–4.
Quantitation of cell condensations. Cultures were monitored
daily by phase contrast and Hoffman modulation contrast micros-
copy for identification of cell condensations (Frenz et al., 1989). On
day 3 or 4, condensations were counted and counts recorded.
Quantitative Alcian blue staining of cultures. Cultures were
fixed on day 7 with a solution of 10% formalin  1% cetyl
pyridinium chloride, then stained with Alcian blue 8GX, pH 1.0, a
stain which at this pH binds specifically to sulfated glycosamino-
glycans (S-GAG) (Lev and Spicer, 1964) in the matrix of chondrify-
ing cells. After washing cultures to remove unbound stain, matrix-
bound stain was extracted overnight with a solution of 8 M
guanidine hydrochloride and measured spectrophotometrically
(Hassell and Horigan, 1982) by using a Biotek microplate reader
equipped with a 600-nm wavelength filter.
Oligonucleotides. Oligonucleotides, as listed, were prepared as
purified products by Genosys Biotechnologies Inc. (The Wood-
lands, Texas): Shh antisense oligonucleotide (AS), complementary
to position 28–42 of the murine Shh gene (5-AGCAAGG-
ATCACCAG-3) (Echelard et al., 1993); Shh sense oligonucleotide
(5-CTGTGATCCTTGCT-3); Shh scrambled AS (5-CAGGATA-
CGCAAGAC-3); and (ATG)-globin AS (5-AGTCCCGTTCA-
CCAT-3) (Hansen et al., 1982). Absence of homology of the Shh AS
to other members of the hedgehog gene family was confirmed by
sequence comparison in the NCBI GenBank database using the
BLAST algorithm.
Indirect immunofluorescent staining of cultures. Cultures
were grown on Lab-Tek culture chambers (Nunc) and fixed in 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). After wash-
ing the fixed cultures in 0.1 M phosphate buffer, an antibody that
specifically recognizes the amino-terminal (19 kDa) Shh peptide
(Marti et al., 1995) was applied for 30 min at room temperature.
Controls were prepared by omission of primary antibody. Cultures
were washed and an FITC-conjugated secondary antibody was
applied for 30 min (at room temperature). Specimens were exam-
ined on a Zeiss Axiophot by using a FITC epifluorescence blue
wavelength (450–490 nm) excitation filter set. In selected speci-
mens, Shh antibody was preincubated with Shh peptide to control
for antibody specificity.
Immunohistochemistry. Inner ear specimens were fixed in
methacarn fixative, dehydrated in methanol, cleared in Histoclear
(National Diagnostics), and embedded in paraffin (Surgipath).
Deparaffinized sections (5–6 m) were processed for immunolocal-
ization by using the avidin-biotin complex (ABC) method (Vector)
(Frenz et al., 1992). The deparaffinized sections were pretreated for
30 min in 100% methanol 0.3% peroxide, following the blocking
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of nonspecific binding sites with normal rabbit serum. Sections
were covered with an optimal dilution of primary antibody (anti-
Shh, described above) and incubated overnight at 4°C in a humidi-
fied chamber. Controls were prepared by omission of primary
antibody or by replacing it with bovine serum albumin. After
incubation with secondary biotinylated antisera and ABC reagent,
sections were subjected to 0.05% 33-diaminobenzidine tetrahy-
drochloride in 0.05 M Tris buffer with 0.01% hydrogen peroxide.
Sections were stained for 15 min, then counterstained with Mayers
hematoxylin (Sigma), and mounted in Crystalmount (Biomedia),
with final mounting in Permount (Fisher Scientific). The pattern of
immunostain distribution was qualitatively evaluated by two
investigators. Evaluations were performed on five to six sections
from each of the inner ears of three embryos per age group. Some
specimens from Shh null mutant mice and their wild-type litter-
mates were immunostained as described above for Pax2. Antibody
against Pax2 was purchased from Zymed Laboratories.
Histology. Inner ear specimens from Shh null homozygote
embryos, their wild-type littermates, and CBA C57/BL6 mouse
embryos were either sectioned and stained with toluidine blue, a
stain which imparts a pink to scarlet metachromasia to tissue
containing S-GAG, or processed for Alcian blue/Alizarin red stain-
ing (Chiang et al., 1996). Evaluation was performed on all sections
from a total of 16 inner ears from Shh null homozygote mice (6
different litters): 4 inner ears at age E10.5 days, 4 at E12.5 days, 6 at
E15 days, and 2 at E17.5 days.
Total RNA preparation and reverse-transcription PCR. Total
RNA was isolated (RNAssay Kit; Qiagen) from mouse otic epithe-
lium and periotic mesenchyme of age E10.5 and E12 days, and from
E10.5 mouse forelimb and adult mouse kidney and lung. Total
RNA was reverse-transcribed to first-strand cDNA by using the
SuperScript Preamplification System (Gibco). The second DNA
strand was synthesized by using Taq polymerase (Perkin-Elmer)
and oligomers specific for Shh. The PCR conditions were 94°C for
60 s and 62°C for 45 s for a total of 35 cycles. Aliquots (25 l) of
each amplified product were electrophoresed on an ethidium
bromide-stained gel. The oligomers were: forward, 5-GTTCC-
TAGTGGTCTTTTGTAGA-3; reverse, 5-GTTAATGTTGGGG-
TCGTAGTAT-3. Amplified products were digested with AluI
(New England Biolabs) to verify that they included nucleotide
sequences corresponding to Shh. The restriction digestion products
were electrophoresed on a 1% agarose gel.
Shh null mutant mice. Mice homozygous for mutation of the
amino-terminal domain structure of Shh were as described (Chiang
et al., 1996).
Genotyping. Genotypings were made by PCR analysis using
DNA isolated from the tail tip. The Shh-specific primers were as
follows: 5-GACCATGTCTGACACTTAGGTTCC-3 and 5-GA-
AGGCCAGGAGGAGAAGGCTCAC-3, as described (Chiang et
al., 1996). PCR conditions were 35 cycles of denaturation for 30 s at
94°C, reannealing for 1 min at 64°C, and extension for 1 min at
72°C. PCR products were separated in agarose gels and visualized
by ethidium bromide staining.
RESULTS
Shh distribution in the embryonic mouse inner ear. An
antibody that specifically recognizes the 19-kDa amino-
terminal peptide of Shh (Marti et al., 1995) defines the
temporal–spatial distribution of this peptide in the epithe-
lial and mesenchymal tissues of the developing mouse
inner ear from E10.5 to E14 days. Immunoreaction product
was present in the epithelium of the E10.5 otocyst, with the
greatest intensity along its lateral wall and in the cells
bordering the developing statoacoustic ganglion complex
(Fig. 1A). Immunostaining of the mesenchyme surrounding
the lateral aspect of the E10.5 otocyst was detected. Immu-
nolabeling was absent in negative control specimens (Fig.
1B). Reaction product was present over the epithelial tissue
of the E12 otocyst, with intense staining for Shh localized
to the ventromedial aspect of the forming cochlear duct
(Fig. 1C). The condensing periotic mesenchyme surround-
ing the lateral wall of the E12 otocyst was immunolabeled.
By E14 days, immunoreaction product was localized over
the epithelium of the developing utricle, saccule, cochlear
duct, semicircular ducts, and the now distinct vestibular
and acoustic ganglia (Figs. 1D–1F). The periotic mesen-
chyme surrounding the developing semicircular ducts was
labeled for the presence of Shh (Fig. 1F).
Shh gene expression in the developing mouse inner ear.
To determine whether the Shh gene is expressed in the
developing mouse inner ear, RT-PCR with Shh-specific
oligonucleotide was performed. Bands corresponding to the
predicted size of the amplified Shh product (240 bp) were
produced from E10.5 and E12 periotic mesenchyme and otic
epithelium (Fig. 2A), as well as from E10.5 forelimb, adult
kidney, and adult lung. A band corresponding to -actin
could be amplified from the same samples, indicating intact
RNA (Fig. 2B). Amplified products corresponding to Shh
(Fig. 2A) were digested with AluI to verify that they in-
cluded nucleotide sequences. The predicted size fragments
(141 and 99 bp) were separated on a 1% agarose gel (Fig. 2C).
Effect of Shh peptide on chondrogenesis. The expres-
sion pattern of endogenous Shh in the embryonic mouse
inner ear suggested a role for Shh in otic epithelial–periotic
mesenchymal tissue interactions. To address this, the abil-
ity of exogenous Shh to initiate chondrogenesis in cultured
periotic mesenchyme was tested. E10.5 periotic mesen-
chyme requires the presence of otic epithelium or the
appropriate growth factors for initiation of chondrogenesis
(Frenz and Van De Water, 1991; Frenz et al., 1992, 1994,
1996; Frenz and Liu, 1998). Cultures of E10.5 periotic
mesenchyme were prepared and grown either in the pres-
ence or absence of otic epithelium or exogenous Shh pep-
tide (amino-terminal 19 kDa). Cell condensations were
counted on day 3 as an early index of chondrogenesis; then,
on day 7, the extent of chondrogenesis was measured by
spectrophotometric quantitation (optical density, OD) of
matrix-bound Alcian blue stain, pH 1.0. Whereas cultures
of E10.5 periotic mesenchyme alone (no Shh, no epithe-
lium) did not differentiate into cartilage (n  5 cultures; 0
condensations per culture; mean OD  0.037  0.02),
cultures of E10.5 periotic mesenchyme containing otic
epithelium developed mesenchymal condensations (n  5
cultures; mean number of condensations 36 3; 100% of
cultures developed condensations), as pictured in Fig. 3A,
and subsequently bound Alcian blue stain (mean OD 
0.234  0.06). In contrast, in cultures in which Shh peptide
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(10 ng/ml; 24 h, 48 h, or 7 days) was substituted for otic
epithelium, mesenchymal condensations did not form (n 
3 cultures per treatment; 0 condensations per culture) (Fig.
3B) and binding of Alcian blue stain did not occur (mean
OD  .039  0.01; Shh, 48 h) even after 7 days in vitro.
Treatment of cultured E10.5 periotic mesenchyme with
Shh peptide at a concentration as low as 1 ng/ml or as high
as 100 ng/ml for 24 or 48 h, or for the duration of the culture
period (i.e., 7 days), did not result in the formation of
mesenchymal condensations (n  2 cultures per treatment;
0 condensations per culture). Although Shh alone did not
appear to be sufficient to initiate condensation formation in
cultures consisting only of E10.5 periotic mesenchyme,
when Shh (10 ng/ml; 48 h) was added to cultures of periotic
mesenchyme that also contained otic epithelium (i.e., peri-
otic mesenchyme  otic epithelium; n  5 cultures), mean
values for condensation number and binding of Alcian blue
stain were respectively increased by 41% (mean condensa-
tion number  61  5; 100% of cultures developed conden-
sations) and 42% (mean OD  0.404  0.04) in comparison
to mean values in the untreated periotic mesenchyme 
otic epithelium cultures (mean condensation number 
36  3; mean OD  0.234  0.06, as indicated above).
Treatment of E10.5 periotic mesenchyme otic epithelium
with 1 ng/ml of Shh (n  5 cultures) did not significantly
enhance chondrogenesis.
Effect of growth factor combinations on chondrogenesis.
It was reasoned that in cultured periotic mesenchyme 
otic epithelium, the ability of the mesenchyme to respond
to exogenous Shh peptide may be dependent on signaling
molecules endogenous to the otic epithelium. To address
this, TGF1, FGF2, or BMP2, i.e., growth factors present in
otic epithelium (Frenz et al., 1992, 1994, 1996), were
substituted for otic epithelium and tested for their ability to
evoke a chondrogenic response in the presence or absence of
added Shh. FGF2 (1 ng/ml), TGF1 (1 ng/ml), or BMP2 (1
ng/ml) was added 1 h after cell seeding to cultured E10.5
periotic mesenchyme, either alone or in combination with
Shh (10 ng/ml), for 48 h. Control cultures were prepared
from periotic mesenchyme alone (no growth factors, no
epithelium). Control mesenchymal cultures or cultures
treated only with Shh, TGF1, or BMP2 did not develop cell
condensations and, consequently, did not differentiate into
cartilage (Table 1). In FGF2-treated cultures, condensation
formation and binding of Alcian blue stain occurred, but to
a limited extent (Table 1). However, when a combination of
sity in the ventral aspect of the forming cochlear duct (arrowhead).
The condensing periotic mesenchyme surrounding the lateral
aspect of the otocyst is labeled (arrows). The developing endolym-
phatic duct (E) and forming semicircular ducts (SD) are indicated.
(D–F) E14 inner ear, showing immunostaining of the (D) developing
saccule (S) and utricle (U); (E) cochlear duct (CD) and acoustic
ganglia (AG); and (F) periotic mesenchyme (arrows) surrounding the
developing semicircular ducts. Bar, 100 m.
FIG. 1. Distribution of Shh. (A) E10.5 mouse inner ear, showing
immunolabeling of the epithelium of the otocyst (O), the cells
bordering the statoacoustic ganglion complex (arrowhead; SAG),
and the lateral periotic mesenchyme. The developing brain is
indicated (Br). (B) E10.5 mouse inner ear, negative control, showing
absence of immunostain. (C) E12 mouse inner ear, demonstrating
immunolabel over the otocyst epithelium, with particular inten-
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Shh  FGF2 was added to cultured E10.5 periotic mesen-
chyme, a 53 and 49% increase in mean values for conden-
sation number and binding of Alcian blue stain, respec-
tively, occurred in comparison to cultures treated only with
FGF2, evoking a chondrogenic response comparable to that
which occurred in the presence of otic epithelium (Table 1).
In contrast, addition of Shh (10 ng/ml) in combination with
FIG. 2. Expression of Shh in mouse tissues, assessed by RT-PCR. Lanes: 1, negative control; 2, E10.5 otic epithelium; 3, E10.5 periotic
mesenchyme; 4, E12 otic epithelium; 5, E12 periotic mesenchyme; 6, E10.5 forelimb; 7, adult lung; 8, adult kidney. (A) Agarose gel showing
that a band corresponding to Shh could be amplified from otic epithelium and periotic mesenchyme at embryonic ages E10.5 and E12 days,
and from the developing E10.5 forelimb, adult kidney, and adult lung. (B) Expression of -actin was used as a control. (C) Amplified product
from E10.5 otic epithelium in (A) was digested with AluI to confirm the presence of nucleotide sequences. The predicted size fragments (99
and 141 bp) were separated on a 1% agarose gel.
FIG. 3. (A) Day 3 culture of E10.5 periotic mesenchyme  otic
epithelium, showing cell condensations (C). (B) When Shh was
substituted for otic epithelium, mesenchymal cell condensations
did not form. Bar, 35 m.
TABLE 1
Effect of Growth Factor Combinations on Otic
Capsule Chondrogenesis
Treatment Condensation number Alcian blue stain
Control 0 0.043  0.02
Shh 0 0.040  0.02
TGF1 0 0.043  0.02
Shh  TGF1 0 0.052  0.03
BMP2 0 0.049  0.01
Shh  BMP2 0 0.047  0.02
FGF2 16  1 0.117  0.03
Shh  FGF2 34  1a 0.230  0.01a
Otic epithelium 35  2 0.232  0.03
Note. Shh (10 ng/ml), FGF2 (1 ng/ml), TGF1 (1 ng/ml), or BMP2
(1 ng/ml) were added alone or in combination to cultured E10.5
periotic mesenchyme. Some cultures contained otic epithelium
instead of growth factors. Control cultures were untreated. Values
provided are the mean  SEM (3–5 cultures per expt. group).
a Comparison of Shh  FGF2-treated cultures to FGF2-treated
cultures indicates statistical significance (at P  0.05; Student’s t
test).
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either BMP2 (1 ng/ml) or TGF1 (1 ng/ml) had no effect on
the chondrogenic response of cultured E10.5 periotic mes-
enchyme. Similarly, condensations did not form when 10
ng/ml of TGF1 or BMP2 was tested either alone or in
combination with Shh (10 ng/ml) (n  2 cultures per
experimental group).
Modulation of Shh expression by antisense oligonucleo-
tide (AS). The distribution pattern of endogenous Shh and
the ability of Shh AS to modulate this expression pattern
was demonstrated in cultured periotic mesenchyme  otic
epithelium of embryonic age E14 days, since at this devel-
opmental stage in vivo, Shh is present throughout the otic
epithelium and in regions of surrounding periotic mesen-
chyme (Figs. 1D–1F). Cultures were treated for 24 h with
Shh AS and then fixed and immunofluorescently labeled for
the presence of endogenous Shh protein. Control cultures
were either treated with Shh sense oligonucleotide (60
g/ml) or were untreated. Intense staining for Shh was
detected in the otic epithelium of control cultures, with a
pale immunolabel in the surrounding periotic mesenchyme
(Figs. 4A and 4C). In contrast, in Shh AS-treated (60 g/ml)
cultures, staining for Shh in the otic epithelium was re-
duced to a faint pattern of immunofluorescence, while
immunostaining of the surrounding periotic mesenchyme
was absent (Figs. 4B and 4D). Five Shh AS-treated cultures
were examined for fluorescent Shh immunolabel. The most
intensely labeled of these specimens is depicted in Fig. 4D.
Effect of Shh antisense oligonucleotide on chondrogen-
esis. Since Shh AS treatment of cultured periotic mesen-
chyme  otic epithelium can decrease endogenous levels of
Shh, we tested the effect of Shh AS on chondrogenesis.
Cultures of E10.5 periotic mesenchyme  otic epithelium
were grown in the presence or absence of 60 g/ml of 1 M
Shh AS, Shh sense oligonucleotide, Shh scrambled AS, or
-globin AS. Mean values for condensation number and
optical density of matrix-bound Alcian blue stain were
comparable in untreated control cultures and cultures
treated with Shh sense or Shh scrambled AS (Table 2). In
contrast, in cultures treated with Shh AS, mean values for
condensation number and binding of Alcian blue stain were
respectively decreased by 70 and 65% in comparison to
sense oligonucleotide-treated control cultures (Table 2).
Treatment of mesenchyme  epithelium cultures with
-globin AS had no effect on chondrogenesis (Table 2).
Rescue of Shh antisense oligonucleotide-treated cul-
tures. To determine the specificity of Shh AS-induced
chondrogenic suppression, rescue experiments were de-
TABLE 2
Effect of Shh Oligonucleotides on Otic Capsule Chondrogenesis
in E10.5 Periotic Mesenchyme  Otic Epithelium
Treatment Condensation number Alcian blue stain
Control 38  2 0.243  0.02
-globin AS 38  1 0.246  0.01
Shh sense 47  1 0.285  0.05
Shh scrambled 46  1 0.286  0.02
Shh AS 14  3a 0.101  0.02a
Note. Cultured E10.5 periotic mesenchyme  otic epithelium
was grown with or without oligonucleotides (60 g/ml; 1 M) for 7
days. Values provided are the mean  SEM (3–6 cultures per expt.
group).
a Comparison of Shh AS-treated cultures to sense oligo-
nucleotide-treated cultures indicates statistical significance (P 
0.05; Student’s t test).
TABLE 3
Rescue of Cell Condensations in Shh AS-Treated Cultures
by Shh Supplementation
Treatment
Condensation number (day 4)
Expt. 1 Expt. 2 Expt. 3
Control 37 35 38
Shh AS 19 12 17
Shh AS  Shh peptide 36 29 35
Note. Cultured E10.5 periotic mesenchyme  otic epithelium
was grown in the presence or absence of Shh AS at either 30 g/ml
(Expt. 1) or 60 g/ml (Expts. 2 and 3) (days 1–4), then treated or not
treated with Shh peptide (75 ng/ml; days 2–4).
FIG. 4. Cultured E14 periotic mesenchyme otic epithelium. (A,
B) Differential interference contrast micrographs of control (A) and
Shh AS-treated (B) cultures, showing the epithelium (E) and sur-
rounding mesenchyme. (C, D) Fluorescent micrographs of the same
fields as (A) and (B), showing bright immunofluorescent label for
Shh in the epithelium and pale immunofluorescence in the sur-
rounding mesenchyme (C) contrasted by a faint level of immuno-
fluorescence in the epithelium following Shh AS treatment (D).
Bar, 35 m
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signed in which Shh peptide (75 ng/ml) was added on days
2–4 to E10.5 periotic mesenchyme  otic epithelium
treated with Shh AS (days 1–4). In each of the three rescue
experiments performed, numerous cell condensations
(Table 3) developed in control cultures. Condensation num-
ber was decreased by 49% in a culture treated with 30
g/ml Shh AS (Expt. 1), and by 66% (Expt. 2) and 55% (Expt.
3) in cultures treated with 60 g/ml Shh AS in comparison
to their respective control cultures (Table 3). However,
when Shh peptide (75 ng/ml) was added to the Shh AS-
treated cultures, the cultures demonstrated values for con-
densation number that were comparable to the untreated
control cultures (Table 3).
Inner ear phenotype in Shh null homozygote mice. It
was reasoned that if blocking of Shh signaling with Shh AS
can suppress chondrogenesis, and therefore epithelial–
mesenchymal interactions in vitro, then consequences to
the inner ear are likely to be produced by inactivation of the
Shh gene in vivo. We examined a developmental series of
inner ears from Shh null homozygote (Shh/) mice and
FIG. 5. E10.5–E15 mouse inner ears, sectioned and stained with toluidine blue. (A) E10.5 wild-type otocyst (O), demonstrating a typical
spherical morphology with an endolymphatic projection (E) and statoacoustic ganglion complex (SAG). (B) E10.5 Shh null homozygote
mouse otocyst (O) demonstrating morphology comparable to that of its wild-type littermate in (A). (C) Wild-type otocyst at E12.5 days
showing the developing cochlear duct (CD), semicircular duct (SD), endolymphatic duct (E), and ganglion (G). (D) E12.5 Shh null
homozygote mouse otocyst (O), demonstrating only an elongated ovoid shape without distinct outgrowth of a cochlear duct or development
of a utricle, saccule, and semicircular ducts. A developing endolymphatic duct (E) is present. (E) Normal development of the cochlear duct
(CD), saccule (S), utricle (U), and vestibular and acoustic ganglia (VG, AG) in a CBA C57/BL6 embryo at age E15 days. A chondrified,
metachromatic capsule (CC) surrounds these epithelial-derived structures. (F) E15 Shh null homozygote inner ear, demonstrating
rudimentary development of the cochlear duct (CD) and semicircular duct (SD). The developing capsule is not well-defined, and the ganglia
are absent. (G) Normal development of the inner ear in an E15 Shh wild-type embryo, showing the cochlear duct (CD), utricle (U),
semicircular duct (SD), and a well-defined metachromatic capsule (CC). (H) An E15 Shh null mutant inner ear, showing a rudimentary
cochlear duct (CD) and a large utriculosaccular space (U-S). A metachromatic capsule surrounds the utriculosaccular space, contrasted by
the presence of only condensing periotic mesenchyme surrounding the rudimentary cochlear duct. No developing semicircular ducts were
observed. The developing brain is indicated (Br). Bar (A, B, D), 100 m; (C, E–H), 200 m
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their wild-type littermates or normal (CBA C57/BL6) em-
bryos by gross stereomicroscopic and serial section analysis
using the developing brain as a landmark for inner ear
identification. Normal development of the inner ear was
observed in each of the wild-type E10.5 embryos (Fig. 5A).
The E10.5 otocyst was spherical in morphology with a
well-defined statoacoustic ganglion situated in the ventro-
medial aspect of its anterior portion. The otocyst had a
well-defined endolymphatic projection, i.e., the anlage of
the future endolymphatic duct and sac The morphology of
the otocyst from E10.5 Shh null mutant embryos resembled
the morphology of the otocyst from the E10.5 wild-type
embryos (Fig. 5B). However, expression of Pax2, a marker of
putative sensory epithelium in the developing mouse inner
ear (Cantos et al., 2000), was different. In wild-type and
normal (CBA C57/BL6) E10.5 embryos, Pax2 protein local-
ized to the ventromedial wall of the otic vesicle (Fig. 6A),
whereas in Shh null mutant embryos of the same develop-
mental age (E10.5), immunostaining for Pax2 was markedly
reduced (Fig. 6B). Normal development of the cochlear duct,
utricle and saccule, and semicircular ducts was evident in
inner ears from wild-type embryos of age E12.5 days (Fig.
5C). This is contrasted by specimens from E12.5 Shh null
homozygote mice, in which an abnormal inner ear pheno-
type was now observed. These mutant specimens (i.e.,
Shh/) were characterized by elongated ovoid shapes with-
out distinct cochlear and vestibular portions (Fig. 5D).
Outgrowth of the cochlear duct had not yet occurred, and
development of the anlagen that forms the superior and
posterior semicircular ducts, which typically starts on E12
as a projection from the otocyst dorsal wall, was not
observed. A developing endolymphatic duct was present. In
wild-type and CBA C57/BL6 embryos of age E15 days, the
inner ear developed a coiled cochlear duct, utricle, saccule,
semicircular ducts, and distinct vestibular and acoustic
ganglia (Figs. 5E and 5G). A well-defined, metachromatic
capsule contoured around the developing otocyst of the
wild-type and CBA C57/BL6 embryos (Figs. 5E and 5G). In
contrast, in each of the Shh null homozygote specimens,
the inner ear was severely malformed (Figs. 5F and 5H). The
cochlear duct of the mutant E15 inner ears was either
rudimentary, without distinct organization of the sensory
epithelium (n  4), or absent (n  2) (Figs. 5F and 5H). In
two of the null mutant specimens, the semicircular ducts
were absent, and a large, irregularly shaped utriculosaccular
space developed (Fig. 5H). A well-differentiated metachro-
matic capsule contoured around this utriculosaccular
space, contrasted by the yet undifferentiated condensing
mesenchyme that surrounded a rudimentary cochlear duct
(Fig. 5H). In all other E15 null mutant specimens examined
(n  4), the developing otic capsule was poorly defined and
not as advanced as in their wild-type littermates or CBA
C57/BL6 embryos, demonstrating regions of condensing
mesenchyme with only pale metachromasia (Fig. 5F). A
disorganized auditory ganglion and vestibular ganglion
were present in two of the Shh null mutant inner ears;
however, in the remaining specimens (n  4), the auditory
and vestibular ganglia were not detected. The most extreme
case of inner ear malformation by targeted Shh mutation
was observed in an E17.5 Shh null homozygote embryo, in
which the inner ear developed as a cystic fingerlike projec-
FIG. 7. E17.5 mouse heads, stained with Alcian blue and Alizarin
red. (Top) Wild-type embryo, demonstrating normal development
of the inner ear. The semicircular ducts (SD) and cochlear duct (CD)
are indicated. (Bottom) Shh null mutant embryo, demonstrating
development of the inner ear as a cystic structure (arrow). The pars
superior (PS) and pars inferior (PI) portions, from which would
normally develop the vestibular and cochlear regions of the inner
ear respectively, are indicated. S, skull; M, mandible
FIG. 6. E10.5 mouse otocysts, immunostained for Pax2. Compari-
son of (A) with (B) shows localization of Pax2 to the ventromedial
wall of the wild-type otocyst (A) contrasted by a marked decrease in
Pax2 immunostaining in the Shh null homozygote otocyst (B). Bar,
100 m
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tion, with no organization into distinct cochlear and ves-
tibular portions (Fig. 7) in comparison with the normal
inner ear development of its wild-type littermate.
DISCUSSION
The capsule of the mammalian inner ear develops by
chondrification of periotic mesenchyme in response to
inductive signals from otic epithelium. Shh is a secreted
molecule expressed by signaling centers during embryonic
development, including the notochord, floorplate, and api-
cal ectodermal ridge. In this study, we demonstrate a role
for Shh in inner ear development and in regulation of the
epithelial–mesenchymal tissue interactions that guide
chondrification of its surrounding cartilaginous capsule.
The distribution pattern of endogenous Shh in the devel-
oping mouse inner ear suggests the involvement of this
signaling molecule both in inner ear morphogenesis and in
the inductive interactions that guide the chondrification of
its surrounding capsule. Between E10.5 and E14 days, i.e.,
the time period corresponding to the onset and completion
of otic capsule differentiation, Shh was present in the inner
ear at sites of active epithelial–mesenchymal interactions
(Fig. 1). The specificity of this distribution for Shh was
demonstrated in negative control specimens by the absence
of Shh immunoreactivity (Fig. 1B). Consistent with these
findings, interactions between epithelial and mesenchymal
tissues are required for the development of integumental,
urogenital, gastrointestinal, and respiratory organs, each of
which is characterized by the temporal–spatial expression
of Shh (Iseki et al., 1996; Urase et al., 1996). Localization of
Shh to the cells bordering the developing statoacoustic
complex at E10.5 days (Fig. 1A) and the intensity of immu-
nostain deposition at the ventromedial aspect of the otocyst
epithelium at E12 days (Fig. 1C) suggest functional speci-
ficity for Shh in the inner ear in roles that may also include
neuronal specification and cochlear duct formation. In
support of this, a low level of immunostaining for Shh was
detected in the ventromedial aspect of the E10.5 otocyst,
i.e., the site of the future cochlear duct (Fig. 1A). The
presence of Shh immunoreactivity in the mesenchyme
surrounding the lateral aspect of the otocyst at E10.5 days
(Fig. 1A) precedes mesenchymal cell condensation, suggest-
ing a role for Shh in otic capsule cartilage formation. Since
this process is initiated by otic epithelium (Frenz and Van
De Water, 1991), immunoreactivity for Shh in the lateral
periotic mesenchyme may result from the secretion of Shh
cleavage product that was processed in neighboring Shh-
expressing otic epithelial cells. The persistence of immu-
nostaining for Shh in regions of mesenchyme immediately
surrounding the semicircular ducts at E14 days (Fig. 1F)
supports the continued involvement of Shh in later inner
ear morphogenetic events, including perilymphatic space
formation, a process involving the turning off of chondro-
genic differentiation (Frenz and Van De Water, 1991;
McPhee and Van De Water, 1986). In the developing limb,
Shh regulates anterioposterior patterning (Riddle et al.,
1993), while the related signaling molecule Indian hedgehog
regulates cartilage formation (Vortkamp et al., 1996).
To model the effects of Shh on otic capsule chondrogen-
esis in situ, Shh peptide was added to cultured E10.5 mouse
periotic mesenchyme. Shh alone, regardless of concentra-
tion or duration of exposure, was not sufficient to initiate
chondrogenesis (Fig. 3). This is in contrast to cultures of
presomitic mesoderm, in which exposure to Shh sufficed to
elicit chondrogenic differentiation (Murtaugh et al., 1999).
However, when grown in the presence of otic epithelium,
E10.5 periotic mesenchyme was responsive to exogenous
Shh, resulting in a significant enhancement of chondrogen-
esis in comparison with untreated control cultures of
periotic mesenchyme  otic epithelium. In accord with
previous studies (Frenz et al., 1994), FGF2 initiated chon-
drogenesis in cultured E10.5 periotic mesenchyme, but only
to a limited extent (Table 1). Since a full chondrogenic
response, i.e., a chondrogenic response comparable to that
evoked by otic epithelium, was elicited in cultured periotic
mesenchyme by a combination of Shh  FGF2, but not by
either Shh or FGF2 (Table 1), synergistic interactions be-
tween these two signaling peptides are implicated in the
chondrogenic control of otic capsule differentiation. In
contrast, a combination of Shh and either BMP2 or TGF1
had no significant effect on the chondrogenic response of
cultured E10.5 periotic mesenchyme, suggesting specificity
in evoking the response of periotic mesenchyme to the Shh
signal. These findings are consistent with studies which
show that addition of FGF proteins can rescue the inductive
effects of otic epithelium in cultured E10.5 periotic mesen-
chyme (Frenz et al., 1994; Frenz and Liu, 1998), while
TGF1 and BMP act as enhancers and/or suppressors of
chondrogenesis in already competent periotic mesenchyme
(Frenz et al., 1992, 1996). Similarly, in the developing limb,
Shh alone is insufficient to induce mesodermal prolifera-
tion or gene expression in the absence of the apical ectoder-
mal ridge (AER); however, in the presence of AER-derived
FGF4, Shh induces the expression of secondary signaling
molecules (Laufer et al., 1994). In cultured presomitic
mesoderm, BMPs can promote chondrogenic differentiation
of somitic mesoderm following exposure to Shh (Murtaugh
et al., 1999).
The ability of Shh AS to suppress chondrogenesis in
cultured E10.5 periotic mesenchyme  otic epithelium in
comparison with Shh sense oligonucleotide-treated control
cultures (Table 2) suggests that Shh, although insufficient
to independently elicit chondrogenesis, is essential to the
chondrogenic process in the developing otic capsule. The
marked decrease in immunofluorescence for Shh following
treatment with Shh AS in comparison with the intensity of
immunofluorescence in Shh sense oligonucleotide-treated
or untreated control cultures (Fig. 4) suggests that this
suppression of chondrogenesis is due to a decline in endog-
enous Shh and is in accord with studies which demon-
strated reduced levels of FGF3 in cultures treated with
FGF3 AS (Frenz and Liu, 1998). In support of this, supple-
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mentation of Shh AS-treated cultures with Shh peptide (75
ng/ml) could restore the chondrogenic response of the
cultured periotic mesenchyme cells to normal levels (Table
3). Furthermore, the specificity of the chondrogenic sup-
pression by Shh AS is supported by the ineffectiveness of
Shh scrambled AS in culture, while lack of an effect by
treatment with -globin AS verifies that the suppression of
chondrogenesis by Shh AS is not due to cellular toxicity.
Moreover, the partial rather than total inhibition of chon-
drogenesis by Shh AS (Table 2) is consistent with the
involvement of other growth factor families, including
FGFs, in the process of otic capsule differentiation (Frenz et
al., 1992, 1994, 1996).
Consistent with our immunostaining results (Fig. 1),
RT-PCR demonstrated that a region of the predicted size of
Shh product was amplified from E10.5 and E12 mouse
periotic mesenchyme and otic epithelium (Fig. 2A), indicat-
ing that the gene for Shh is expressed in the developing
mouse inner ear. Restriction digestion verified that the
amplified products included nucleotide sequences corre-
sponding to Shh (Fig. 2C). In accord with previous studies,
expression of Shh was also demonstrated in developing
limb and adult kidney and lung (Marigo et al., 1995). When
the Shh gene was mutated, leaving coding sequences that
result in a truncated protein due to a loss of residues within
the 19-kDa amino-terminal structure (Chiang et al., 1996),
abnormalities in inner ear development were produced
(Figs. 5–7). At embryonic age E10.5 days, these abnormali-
ties were not phenotypic (Figs. 5A and 5B), but rather,
included a marked decrease in Pax2 protein expression (Fig.
6), suggesting that Pax2 may be a downstream target of Shh
in the developing otic vesicle. In support of this, the Pax2
gene is expressed in the ventromedial portion of the otic
vesicle from which the cochlear and saccular regions of the
inner ear derive (Torres et al., 1996; Cantos et al., 2000).
Moreover, at E17 days, Pax2 null homozygote mice dem-
onstrate agenesis of the spiral ganglion and an unshaped
cochlear duct due to lack of outgrowth from the ventral
portion of the otocyst (Torres et al., 1996). In the developing
eye, overexpression of Shh induces the expression of Pax2,
while, conversely, absence of Shh in the neuroectoderm of
cyclops mutants is associated with a near absence of Pax2
(Macdonald et al., 1995).
As shaping of the otocyst proceeds at E12.5 days to give
rise to cochlear and vestibular structures, the wild-type
inner ear develops normally, as evidenced by the presence
of the forming semicircular ducts, utricle, saccule, and
cochlear duct (Fig. 5C). However, the Shh mutant inner ear
does not develop properly, instead demonstrating an elon-
gated ovoid morphology with a developing endolymphatic
duct, but without outgrowth of a cochlear duct or semicir-
cular ducts (Fig. 5D). Abnormalities in inner ear phenotype
persist in the E15 Shh null mutant otocyst, and include
absence or only rudimentary development of the cochlear
duct, absence of semicircular ducts, formation of a large,
abnormal utriculosaccular space, lack or absence of orga-
nized auditory and vestibular ganglia, and a poorly defined
otic capsule (Figs. 5F and 5H) in comparison with normal
development in wild-type littermates or CBA C57/BL6
embryos (Figs. 5E and 5G). The most extreme phenotype
was evident in an E17.5 Shh null mutant embryo by the
development of the inner ear as a cystic, fingerlike structure
(Fig. 7) in which morphogenesis of auditory and vestibular
anlage was indistinguishable. A similar cystic inner ear
phenotype was observed following in utero exposure of the
developing mouse inner ear to teratogenic doses of all-trans
retinoic acid (Frenz et al., 1996b). In accord with these
findings, which demonstrate inner ear anomalies consistent
with congenital deafness, patients with a point mutation or
deletion in the Shh gene, as demonstrated in cases of
holoprosencephaly, are characterized by sensorineural hear-
ing loss (Belloni et al., 1996; Roessler et al., 1996). A loss of
anterior otic structures and mirror image duplication of
posterior otic structures has been associated with injection
of Shh RNA in zebrafish embryos, supporting a role for Shh
in patterning of the zebrafish otic vesicle (K. L. Hammond,
H. E. Loynes, and T. T. Whitfield, unpublished result).
In summary, this study has defined the expression of Shh
in the developing mouse inner ear, demonstrated its func-
tional role in otic capsule chondrogenesis, and determined
the consequences of blocking the Shh signal either with
antisense oligonucleotide in vitro or by targeted mutation
in vivo. These findings implicate Shh as a signaling mole-
cule that participates in guiding the development of the
inner ear and its surrounding cartilaginous capsule during
embryogenesis in situ.
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